Highlights and Quick Summary
- Trade and Non-Trade Receivables Growth for the quarter ending September 30, 2023 was 2.81 (a -69.41% decrease compared to previous quarter)
- Year-over-year quarterly Trade and Non-Trade Receivables Growth increased by 3103.53%
- Annual Trade and Non-Trade Receivables Growth for 2022 was 0.09 (a -182.74% decrease from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2021 was -0.11 (a -101.72% decrease from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2020 was 6.18 (a -818.04% decrease from previous year)
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Trade and Non-Trade Receivables Growth of Absci Corporation
Most recent Trade and Non-Trade Receivables Growthof ABSI including historical data for past 10 years.Interactive Chart of Trade and Non-Trade Receivables Growth of Absci Corporation
Absci Corporation Trade and Non-Trade Receivables Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 2.81 | 9.18 | 2.79 | – | – |
| 2022 | 0.09 | -0.71 | -0.43 | -0.66 | 0.09 |
| 2021 | – | – | -0.11 | 2.22 | -0.11 |
| 2020 | – | – | – | 0.12 | 6.18 |
| 2019 | -0.69 | – | – | – | -0.86 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology